{"transactions":[{"id":715167,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2026-07-07T00:38:00.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":7700,"price":5.69,"value":43813.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market."}],"balance_after":58752,"source":{"system":"sec-edgar","filing":"0001493152-26-032233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315226032233/ownership.xml","form_type":"4"}},{"id":737746,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2026-06-15T22:22:07.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":26943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest on the date of the next annual meeting of shareholders, subject to the Reporting Person's continued service from the date of grant until the vesting date."}],"balance_after":66452,"source":{"system":"sec-edgar","filing":"0001493152-26-028754","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315226028754/ownership.xml","form_type":"4"}},{"id":1092292,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2025-07-03T20:05:22.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":39509,"source":{"system":"sec-edgar","filing":"0001641172-25-017787","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000164117225017787/ownership.xml","form_type":"4"}},{"id":1411569,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-09-10T18:05:38.000Z","date":"2024-09-06","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, representing a right to purchase a total of 5,000 shares, became exercisable in five equal annual installments beginning on April 29, 2019, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":299.24,"expiration_date":"2029-04-29","underlying":"Bio-Rad A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001062993-24-016386","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016386/form4.xml","form_type":"4"}},{"id":1411568,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-10T18:05:38.000Z","date":"2024-09-06","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":329.9384,"value":989815.2,"ownership":{"direct":true},"balance_after":7559.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016386","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016386/form4.xml","form_type":"4"}},{"id":1411567,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-10T18:05:38.000Z","date":"2024-09-06","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":299.24,"value":897720.0,"ownership":{"direct":true},"balance_after":10559.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016386","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016386/form4.xml","form_type":"4"}},{"id":1417270,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":false,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":903},"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417269,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":633,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":633},"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417268,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1735,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":867},"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417267,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":1252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 1, 2023, the reporting person was granted 5,008 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 1, 2023, the reporting person was granted 5,008 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":3756,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1252},"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417266,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":458,"price":337.32,"value":154492.56,"ownership":{"direct":true},"balance_after":7559.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417265,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":true,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":8017.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417264,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":321,"price":337.32,"value":108279.72,"ownership":{"direct":true},"balance_after":7114.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417263,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7435.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417262,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":440,"price":337.32,"value":148420.8,"ownership":{"direct":true},"balance_after":6802.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417261,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7242.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417260,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":635,"price":337.32,"value":214198.2,"ownership":{"direct":true},"balance_after":6375.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1417259,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T00:19:54.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":1252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 38.5620 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024."}],"balance_after":7010.4501,"source":{"system":"sec-edgar","filing":"0001062993-24-016169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016169/form4.xml","form_type":"4"}},{"id":1459878,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-07-04T01:00:07.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":30000,"derivative":{"exercise_price":2.95,"expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-24-026273","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315224026273/ownership.xml","form_type":"4"}},{"id":1533509,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2024-04-30T21:53:07.000Z","date":"2024-04-29","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001062993-24-009082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324009082/form4.xml","form_type":"4"}},{"id":1533508,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-04-30T21:53:07.000Z","date":"2024-04-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":357,"price":277.11,"value":98928.27,"ownership":{"direct":true},"balance_after":5719.8881,"source":{"system":"sec-edgar","filing":"0001062993-24-009082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324009082/form4.xml","form_type":"4"}},{"id":1533507,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-04-30T21:53:07.000Z","date":"2024-04-29","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9.7660 and 27.5220 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2023 and 03/31/2024, respectively."}],"balance_after":6076.8881,"source":{"system":"sec-edgar","filing":"0001062993-24-009082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324009082/form4.xml","form_type":"4"}},{"id":1583329,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-12T16:29:05.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":5891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":5891,"derivative":{"exercise_price":343.76,"expiration_date":"2034-03-08","underlying":"Bio-Rad A Common Stock","underlying_shares":5891},"source":{"system":"sec-edgar","filing":"0001062993-24-006221","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324006221/form4.xml","form_type":"4"}},{"id":1788568,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-02","kind":"exercise","planned":false,"acquired":false,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":903,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":903},"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788567,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1266,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":633},"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788566,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2022, the reporting person was granted 3,469 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2602,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":867},"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788565,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":5008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":5008,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":5008},"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788564,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":448,"price":394.6,"value":176780.8,"ownership":{"direct":true},"balance_after":5039.6001,"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788563,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-02","kind":"exercise","planned":false,"acquired":true,"shares":903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":5487.6001,"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788562,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":279,"price":394.6,"value":110093.4,"ownership":{"direct":true},"balance_after":4584.6001,"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788561,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":4863.6001,"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788560,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":430,"price":394.6,"value":169678.0,"ownership":{"direct":true},"balance_after":4230.6001,"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1788559,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T18:28:00.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 26.9850 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023."}],"balance_after":4660.6001,"source":{"system":"sec-edgar","filing":"0001062993-23-017654","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017654/form4.xml","form_type":"4"}},{"id":1843441,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-06-28T01:30:16.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":90000,"derivative":{"exercise_price":0.2,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001493152-23-022669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315223022669/ownership.xml","form_type":"4"}},{"id":1843440,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2023-06-28T01:30:16.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":90170,"source":{"system":"sec-edgar","filing":"0001493152-23-022669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315223022669/ownership.xml","form_type":"4"}},{"id":1911079,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-01T16:51:12.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1000,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001062993-23-009749","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323009749/form4.xml","form_type":"4"}},{"id":1911078,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-05-01T16:51:12.000Z","date":"2023-04-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":346,"price":450.79,"value":155973.34,"ownership":{"direct":true},"balance_after":3766.6151,"source":{"system":"sec-edgar","filing":"0001062993-23-009749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323009749/form4.xml","form_type":"4"}},{"id":1911077,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-05-01T16:51:12.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8.8470 and 20.7590 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022 and 03/31/2023, respectively."}],"balance_after":4112.6151,"source":{"system":"sec-edgar","filing":"0001062993-23-009749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323009749/form4.xml","form_type":"4"}},{"id":2164860,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:14:30.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1806,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":902},"source":{"system":"sec-edgar","filing":"0001062993-22-019282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019282/form4.xml","form_type":"4"}},{"id":2164859,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:14:30.000Z","date":"2022-09-02","kind":"tax_withholding","acquired":false,"shares":448,"price":478.32,"value":214287.36,"ownership":{"direct":true},"balance_after":3083.0091,"source":{"system":"sec-edgar","filing":"0001062993-22-019282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019282/form4.xml","form_type":"4"}},{"id":2164858,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:14:30.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":3531.0091,"source":{"system":"sec-edgar","filing":"0001062993-22-019282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019282/form4.xml","form_type":"4"}},{"id":2166856,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T17:56:39.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 2,532 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1899,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":633},"source":{"system":"sec-edgar","filing":"0001062993-22-019194","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019194/form4.xml","form_type":"4"}},{"id":2166855,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T17:56:39.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":3469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":3469,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3469},"source":{"system":"sec-edgar","filing":"0001062993-22-019194","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019194/form4.xml","form_type":"4"}},{"id":2166854,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-06T17:56:39.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":314,"price":486.25,"value":152682.5,"ownership":{"direct":true},"balance_after":2629.0091,"source":{"system":"sec-edgar","filing":"0001062993-22-019194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019194/form4.xml","form_type":"4"}},{"id":2166853,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-06T17:56:39.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16.8874 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2022."}],"balance_after":2943.0091,"source":{"system":"sec-edgar","filing":"0001062993-22-019194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019194/form4.xml","form_type":"4"}},{"id":2178210,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-08-19T12:00:27.000Z","date":"2022-08-17","kind":"purchase","acquired":true,"shares":20000,"price":0.87,"value":17400.0,"ownership":{"direct":true},"balance_after":70170,"source":{"system":"sec-edgar","filing":"0001493152-22-023524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315222023524/ownership.xml","form_type":"4"}},{"id":2181636,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2022-08-18T00:21:44.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":0.97,"expiration_date":"2032-08-15","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-22-023385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315222023385/ownership.xml","form_type":"4"}},{"id":2181635,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-08-18T00:21:44.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":50170,"source":{"system":"sec-edgar","filing":"0001493152-22-023385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315222023385/ownership.xml","form_type":"4"}},{"id":2205333,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-19T20:05:29.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units vested on June 24, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Restricted Stock Units vested on June 24, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-019822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315222019822/ownership.xml","form_type":"4"}},{"id":2205332,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2022-07-19T20:05:29.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40170,"source":{"system":"sec-edgar","filing":"0001493152-22-019822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315222019822/ownership.xml","form_type":"4"}},{"id":2287445,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-02T18:44:00.000Z","date":"2022-04-29","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2000,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001062993-22-011169","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322011169/form4.xml","form_type":"4"}},{"id":2287444,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-05-02T18:44:00.000Z","date":"2022-04-29","kind":"tax_withholding","acquired":false,"shares":471,"price":512.06,"value":241180.26,"ownership":{"direct":true},"balance_after":2293.1217,"source":{"system":"sec-edgar","filing":"0001062993-22-011169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322011169/form4.xml","form_type":"4"}},{"id":2287443,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-05-02T18:44:00.000Z","date":"2022-04-29","kind":"exercise","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13.3620 and 14.8416 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2021 and 03/31/2022, respectively."}],"balance_after":2764.1217,"source":{"system":"sec-edgar","filing":"0001062993-22-011169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322011169/form4.xml","form_type":"4"}},{"id":2580773,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-02","kind":"exercise","acquired":false,"shares":902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2708,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":902},"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580772,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option, representing a right to purchase a total of 5,000 shares, became exercisable in five equal annual installments beginning on April 29, 2020, which was the first anniversary of the date on which the option was granted."}],"balance_after":3000,"derivative":{"exercise_price":299.24,"expiration_date":"2029-04-29","underlying":"Bio-Rad A Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580771,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":2532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":2532,"derivative":{"exercise_price":814.95,"expiration_date":"2031-09-01","underlying":"Bio-Rad A Common Stock","underlying_shares":2532},"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580770,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":2532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":2532,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2532},"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580769,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-02","kind":"tax_withholding","acquired":false,"shares":448,"price":825.77,"value":369944.96,"ownership":{"direct":true},"balance_after":1735.9181,"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580768,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-02","kind":"exercise","acquired":true,"shares":902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":2183.9181,"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580767,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":599,"price":814.09,"value":487639.91,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $814.02 to $814.11, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1281.9181,"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580766,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":651,"price":813.15,"value":529360.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $812.71 to $813.34, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1880.9181,"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580765,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":750,"price":812.27,"value":609202.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $811.70 to $812.69, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2531.9181,"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2580764,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:05:47.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":2000,"price":299.24,"value":598480.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 13.9278 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2021."}],"balance_after":3281.9181,"source":{"system":"sec-edgar","filing":"0001062993-21-008244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008244/form4.xml","form_type":"4"}},{"id":2653413,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-29T00:33:41.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":10000,"derivative":{"exercise_price":0,"exercise_date":"2022-06-24","expiration_date":"2022-06-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-21-015449","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315221015449/ownership.xml","form_type":"4"}},{"id":2653412,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2021-06-29T00:33:41.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":5.46,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-21-015449","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315221015449/ownership.xml","form_type":"4"}},{"id":2670114,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2021-06-15T00:20:16.000Z","date":"2021-06-11","kind":"other","acquired":true,"shares":6993,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3,"exercise_date":"2019-02-01","expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":6993},"source":{"system":"sec-edgar","filing":"0001493152-21-014342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315221014342/ownership.xml","form_type":"4"}},{"id":2670113,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-15T00:20:16.000Z","date":"2021-06-11","kind":"other","acquired":true,"shares":6993,"price":3,"value":20979.0,"ownership":{"direct":true},"balance_after":30170,"source":{"system":"sec-edgar","filing":"0001493152-21-014342","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315221014342/ownership.xml","form_type":"4"}},{"id":2735409,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-04-30T18:31:00.000Z","date":"2021-04-29","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":3000,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001062993-21-003968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321003968/form4.xml","form_type":"4"}},{"id":2735408,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-04-30T18:31:00.000Z","date":"2021-04-29","kind":"tax_withholding","acquired":false,"shares":466,"price":640.73,"value":298580.18,"ownership":{"direct":true},"balance_after":1267.9903,"source":{"system":"sec-edgar","filing":"0001062993-21-003968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321003968/form4.xml","form_type":"4"}},{"id":2735407,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-04-30T18:31:00.000Z","date":"2021-04-29","kind":"exercise","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16.5639 and 14.1410 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2020 and 03/31/2021, respectively."}],"balance_after":1733.9903,"source":{"system":"sec-edgar","filing":"0001062993-21-003968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321003968/form4.xml","form_type":"4"}},{"id":2944400,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-15T11:27:32.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":16184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share."}],"balance_after":23177,"source":{"system":"sec-edgar","filing":"0001493152-20-023597","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315220023597/ownership.xml","form_type":"4"}},{"id":3038405,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-04T19:35:22.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":3610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":3610,"derivative":{"exercise_price":524.3,"expiration_date":"2030-09-02","underlying":"Bio-Rad A Common Stock","underlying_shares":3610},"source":{"system":"sec-edgar","filing":"0001812865-20-000012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000012/edgar.xml","form_type":"4"}},{"id":3038404,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-09-04T19:35:22.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":3610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":3610,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3610},"source":{"system":"sec-edgar","filing":"0001812865-20-000012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000012/edgar.xml","form_type":"4"}},{"id":3104295,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-19T21:34:25.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":57000,"derivative":{"exercise_price":2.38,"underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001493152-20-011542","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315220011542/ownership.xml","form_type":"4"}},{"id":3167133,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-30T18:14:49.000Z","date":"2020-04-29","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in five equal annual installments beginning on April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in five equal annual installments beginning on April 29, 2020."}],"balance_after":4000,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001652252-20-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000165225220000002/edgar.xml","form_type":"4"}},{"id":3167132,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-04-30T18:14:49.000Z","date":"2020-04-29","kind":"tax_withholding","acquired":false,"shares":346,"price":436.27,"value":150949.42,"ownership":{"direct":true},"balance_after":679.9765,"source":{"system":"sec-edgar","filing":"0001652252-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000165225220000002/edgar.xml","form_type":"4"}},{"id":3167131,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-04-30T18:14:49.000Z","date":"2020-04-29","kind":"exercise","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 25.9765 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 3/31/2020."}],"balance_after":1025.9765,"source":{"system":"sec-edgar","filing":"0001652252-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000165225220000002/edgar.xml","form_type":"4"}},{"id":3458711,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-20T00:12:15.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":2.12,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-19-042841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000120919119042841/doc4.xml","form_type":"4"}},{"id":3546319,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-04-30T18:30:01.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests over five years at 20% per year on the yearly anniversary date of the grant."}],"balance_after":5000,"derivative":{"exercise_price":299.24,"expiration_date":"2029-04-29","underlying":"Bio-Rad A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001652252-19-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000165225219000014/edgar.xml","form_type":"4"}},{"id":3546318,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2019-04-30T18:30:01.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant."}],"balance_after":5000,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001652252-19-000014","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000165225219000014/edgar.xml","form_type":"4"}},{"id":3827369,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-09-05T01:45:26.000Z","date":"2018-08-30","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":2.4,"expiration_date":"2028-08-29","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-049414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000120919118049414/doc4.xml","form_type":"4"}},{"id":3857774,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock purchase warrants","published_at":"2018-08-01T01:38:46.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":6993,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":6993,"derivative":{"exercise_price":3,"exercise_date":"2019-02-01","expiration_date":"2024-02-01","underlying":"Common stock","underlying_shares":6993},"source":{"system":"sec-edgar","filing":"0001493152-18-010761","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315218010761/ownership.xml","form_type":"4"}},{"id":3857773,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, no par value","published_at":"2018-08-01T01:38:46.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":6993,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":6993,"source":{"system":"sec-edgar","filing":"0001493152-18-010761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000149315218010761/ownership.xml","form_type":"4"}},{"id":4162148,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-11-15T21:17:27.000Z","date":"2017-11-13","kind":"purchase","acquired":true,"shares":2000,"price":12.1,"value":24200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price of shares purchased in multiple transactions. The reporting person undertakes to provide to Intrexon Corporation (\"Intrexon\"), any security holder of Intrexon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001225385-17-000119","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000122538517000119/edgar.xml","form_type":"4"}},{"id":4233889,"issuer":{"id":4356,"kind":"organization","name":"PRECIGEN, INC.","symbol":"PGEN"},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-08-15T17:14:03.000Z","date":"2017-08-14","kind":"purchase","acquired":true,"shares":2000,"price":19.99,"value":39980.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001225385-17-000102","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000122538517000102/edgar.xml","form_type":"4"}},{"id":4276126,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-20T21:56:06.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":20000,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-041129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000120919117041129/doc4.xml","form_type":"4"}},{"id":4276125,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":32109,"kind":"person","name":"Last Andrew J.","position":1,"cik":"0001485088","reported_name":"Last Andrew J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-06-20T21:56:06.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":6520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options are granted to directors annually. These options are a \"transitional grant\" reflecting the change in the date of the annual grant from February to the date of the annual meeting of shareholders. The options are 32.60% of the annual grant for the 119-day gap between February 16, 2017, one year from the last annual grant, and June 15, 2017, date of the full annual grant for 2017-2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will become exercisable in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018, and one day before the Company's next annual meeting of shareholders, based upon continued service on the board of directors from the date of grant on June 15, 2017."}],"balance_after":6520,"derivative":{"exercise_price":5.1,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":6520},"source":{"system":"sec-edgar","filing":"0001209191-17-041129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485088/000120919117041129/doc4.xml","form_type":"4"}}]}